|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010346,
umls-concept:C0021081,
umls-concept:C0024501,
umls-concept:C0043240,
umls-concept:C0205099,
umls-concept:C0205171,
umls-concept:C0205195,
umls-concept:C0332161,
umls-concept:C0574032,
umls-concept:C0596545,
umls-concept:C0666743,
umls-concept:C1521828,
umls-concept:C1524072
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-6-6
|
|
pubmed:abstractText |
Infliximab (anti-TNF alpha) has been used for the treatment of fistulizing Crohn's disease with variable efficacy. The aim of this study was to evaluate the efficacy of infliximab combined with selective seton drainage in the healing of fistulizing anorectal Crohn's disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0012-3706
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
577-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12792431-Adolescent,
pubmed-meshheading:12792431-Adult,
pubmed-meshheading:12792431-Antibodies, Monoclonal,
pubmed-meshheading:12792431-Combined Modality Therapy,
pubmed-meshheading:12792431-Crohn Disease,
pubmed-meshheading:12792431-Digestive System Surgical Procedures,
pubmed-meshheading:12792431-Drainage,
pubmed-meshheading:12792431-Female,
pubmed-meshheading:12792431-Gastrointestinal Agents,
pubmed-meshheading:12792431-Humans,
pubmed-meshheading:12792431-Immunosuppressive Agents,
pubmed-meshheading:12792431-Infusions, Parenteral,
pubmed-meshheading:12792431-Male,
pubmed-meshheading:12792431-Middle Aged,
pubmed-meshheading:12792431-Rectal Fistula,
pubmed-meshheading:12792431-Retrospective Studies,
pubmed-meshheading:12792431-Treatment Outcome,
pubmed-meshheading:12792431-Wound Healing
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
|
|
pubmed:affiliation |
Department of Surgery, Foothills Hospital, University of Calgary, Calgary, Alberta, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
